Article
RUNX3 in oncogenic and anti‐oncogenic signaling in gastrointestinal cancers
14 Feb 2011
Abstract excerpt
The reputation of RUNX3 as a strong candidate for a tumor suppressor originated from studies of gastric carcinogenesis and now extends to a variety of other human cancers. The RUNX3 transcription factor is a downstream effector of the TGF-β superfamily signaling pathway and has a critical role in the regulation of cell proliferation, cell death by apoptosis, and cell adhesion. Recently, RUNX3 was proposed as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
